Re: Deal of the year in biotech
$400 million is about 2.5 million shares (at $158 per)...and Piney would know better but I think that means they own 3% of the company now. if they prove to be great for us and we work beautifully together, I assume they'd take on LGMD next (in a year from now) for another 2% - or more if we add on still more of our stuff - SanFillipo....and on and on...another 3%? Now they'd be at 10% in 2 years....Then....
...Finally we get to MS and my old Lacerta speculation Alz and Parky and at that point we are in gangbusters territory. Sarepta here in the US and Roche everywhere else.
And if that all plays out, I'd guess the terms would get marginally even sweeter for us as we go. For without our science there ain't nothin' there, right?
All is lookin' good, I must admit. We are picking up speed fast, and in 2 or 3 years we could be in overdrive.